The route to identification of the immunological correlates of protection in ruminants

反刍动物保护免疫相关性的鉴定途径

基本信息

  • 批准号:
    BB/I020519/1
  • 负责人:
  • 金额:
    $ 47.75万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2012
  • 资助国家:
    英国
  • 起止时间:
    2012 至 无数据
  • 项目状态:
    已结题

项目摘要

Effective vaccines are the most efficient way of preventing the transmission and spread of infectious diseases. This applies to diseases of both humans and animals. However there are still many diseases for which no effective vaccines exist. This may be because no vaccines have yet been tested, because vaccines that have been tested do not protect, or because vaccines that have been tested present a hazard in themselves (benefit versus risk). In the past, vaccines were developed empirically. In contrast, strategic approaches to the development of safe and effective vaccines relies on an understanding of how the immune system is activated and regulated so that optimum protection is achieved (benefit) with minimum adverse effects (risk). Investigation of the immune system reveals the correlates of protection that should be mimicked by a good vaccine. Since the correlates of protection are not the same for every infection, vaccines against different diseases need to stimulate different components of the immune system. The capability to identify immunological correlates of protection in farmed ruminants such as cattle and sheep is relatively poor compared to small laboratory animals such as mice that are commonly used as models of human disease. This is largely due to a relative paucity of immunological techniques in ruminants. The most effective way of understanding immune responses to infection is to study the natural host. Cattle and sheep offer an excellent opportunity to do this, and are hosts for economically important diseases, but the lack of knowledge of their immune systems is a major block to strategic vaccine development. Furthermore, these animals may represent better models for developing solutions to human diseases than mice. In this project we aim to develop new techniques to investigate the activation and regulation of the immune systems of cattle and sheep. These techniques will be applied to studies on cells activated under different conditions. This work will facilitate the identification of immunological correlates of protection to many different diseases of cattle and sheep and will also inform on the best ways to deliver new vaccines to maximise their effects. Ultimately this will lead to more strategic approaches to the management and control of infectious diseases of farmed ruminants. This will benefit the agricultural sector and the general public through improved animal welfare, animal production and food security. Furthermore, the work will be done in conjunction with an Industrial Partner, ensuring that the techniques and reagents developed in the project will be made widely available to the research community.
有效的疫苗是预防传染病传播和扩散的最有效方法。这适用于人类和动物的疾病。然而,仍有许多疾病没有有效的疫苗。这可能是因为尚未对疫苗进行测试,因为已测试的疫苗没有保护作用,或者因为已测试的疫苗本身存在危害(益处与风险)。过去,疫苗是凭经验研制的。相比之下,开发安全有效疫苗的战略方法依赖于对免疫系统如何被激活和调节的理解,从而实现最佳的保护(效益)和最小的不良影响(风险)。对免疫系统的研究揭示了一种好的疫苗应该模仿的相关保护。由于每种感染的保护相关因素并不相同,针对不同疾病的疫苗需要刺激免疫系统的不同组成部分。与通常用作人类疾病模型的小实验动物(如小鼠)相比,在牛和羊等养殖反刍动物中识别免疫保护相关因素的能力相对较差。这主要是由于反刍动物免疫技术的相对缺乏。了解对感染的免疫反应最有效的方法是研究自然宿主。牛羊提供了一个很好的机会来做到这一点,它们是经济上重要疾病的宿主,但是缺乏对它们免疫系统的了解是战略疫苗开发的主要障碍。此外,与小鼠相比,这些动物可能是开发人类疾病解决方案的更好模型。在这个项目中,我们的目标是开发新的技术来研究牛和羊的免疫系统的激活和调节。这些技术将应用于在不同条件下活化的细胞的研究。这项工作将有助于确定对牛和羊的许多不同疾病提供保护的免疫学相关性,并将为提供新疫苗以最大限度地发挥其作用的最佳方式提供信息。最终,这将导致管理和控制养殖反刍动物传染病的更具战略性的方法。这将通过改善动物福利、动物生产和粮食安全,使农业部门和公众受益。此外,这项工作将与一个工业伙伴共同完成,确保项目中开发的技术和试剂将广泛提供给研究界。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Phenotypic and functional analysis of monocyte populations in cattle peripheral blood identifies a subset with high endocytic and allogeneic T-cell stimulatory capacity.
  • DOI:
    10.1186/s13567-015-0246-4
  • 发表时间:
    2015-09-25
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Corripio-Miyar Y;Hope J;McInnes CJ;Wattegedera SR;Jensen K;Pang Y;Entrican G;Glass EJ
  • 通讯作者:
    Glass EJ
Exploiting ovine immunology to improve the relevance of biomedical models.
  • DOI:
    10.1016/j.molimm.2014.09.002
  • 发表时间:
    2015-07
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Entrican G;Wattegedera SR;Griffiths DJ
  • 通讯作者:
    Griffiths DJ
The route to identification of immunological correlates of protection in ruminants
反刍动物保护免疫相关性的鉴定途径
Defining CD16+ve subsets in the peripheral blood of cattle
定义牛外周血中的 CD16 ve 亚群
Characterisation of a novel myeloid cell population in cattle blood and its potential involvement with Johne's Disease
牛血液中新型骨髓细胞群的特征及其与约内氏病的潜在关系
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elizabeth Glass其他文献

Theileria. In : Genome Mapping and Genomics in Animal-Associated Microbes.(Eds. V. Nene and C. Kole)
泰勒里亚。
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Richard P. Bishop;David O. Odongo;David J. Mann;Terry W. Pearson;Chihiro Sugimoto;Lee R. Haines;Elizabeth Glass;Kirsty Jensen;Ulrike Seitzer;Jabbar S. Ahmed;Simon P. Graham;Etienne P. de Villiers.
  • 通讯作者:
    Etienne P. de Villiers.
iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA
靶向 iDC 的 PfCSP mRNA 疫苗与传统 mRNA 相比,对疟原虫提供了卓越的保护。
  • DOI:
    10.1038/s41541-025-01089-x
  • 发表时间:
    2025-02-19
  • 期刊:
  • 影响因子:
    6.500
  • 作者:
    Sean Yanik;Varsha Venkatesh;James T. Gordy;Mohamad-Gabriel Alameh;Jacob Meza;Yangchen Li;Elizabeth Glass;Yevel Flores-Garcia;Ying Tam;Nattawat Chaiyawong;Deepti Sarkar;Drew Weissman;Richard Markham;Prakash Srinivasan
  • 通讯作者:
    Prakash Srinivasan
MIP-3α-antigen fusion DNA vaccine enhances sex differences in tuberculosis model and alters dendritic cell activity early post vaccination
MIP-3α-抗原融合 DNA 疫苗增强了结核病模型中的性别差异,并在接种后早期改变了树突状细胞的活性
  • DOI:
    10.1038/s41598-025-06532-6
  • 发表时间:
    2025-07-01
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    James T. Gordy;Rowan E. Bates;Elizabeth Glass;Jacob Meza;Yangchen Li;Courtney Schill;Alannah D. Taylor;Tianyin Wang;Fengyixin Chen;Khaleel Plunkett;Styliani Karanika;Petros C. Karakousis;Richard B. Markham
  • 通讯作者:
    Richard B. Markham
Reliability and performance of a true enhancement mode HIGFET for wireless applications
  • DOI:
    10.1016/j.microrel.2007.02.006
  • 发表时间:
    2007-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Craig Gaw;Thomas Arnold;Elizabeth Glass;Robert Martin
  • 通讯作者:
    Robert Martin
The Earth Microbiome Project: Meeting report of the “1st EMP meeting on sample selection and acquisition” at Argonne National Laboratory October 6th 2010
  • DOI:
    10.4056/aigs.1443528
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
    5.400
  • 作者:
    Jack A. Gilbert;Folker Meyer;Janet Jansson;Jeff Gordon;Norman Pace;James Tiedje;Ruth Ley;Noah Fierer;Dawn Field;Nikos Kyrpides;Frank-Oliver Glöckner;Hans-Peter Klenk;K. Eric Wommack;Elizabeth Glass;Kathryn Docherty;Rachel Gallery;Rick Stevens;Rob Knight
  • 通讯作者:
    Rob Knight

Elizabeth Glass的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elizabeth Glass', 18)}}的其他基金

Genomic Selection for Bovine Tuberculosis Resistance in Dairy Cows
奶牛结核病抗性的基因组选择
  • 批准号:
    BB/L004054/1
  • 财政年份:
    2014
  • 资助金额:
    $ 47.75万
  • 项目类别:
    Research Grant
The interplay between host and pathogen genetics in the increasing incidence of bovine tuberculosis
宿主和病原体遗传学之间的相互作用导致牛结核病发病率增加
  • 批准号:
    BB/E018335/1
  • 财政年份:
    2008
  • 资助金额:
    $ 47.75万
  • 项目类别:
    Research Grant
Faraday earmarked proposal: Toll-like receptors and dendritic cell genetic heterogeneity
法拉第专项提案:Toll 样受体和树突状细胞遗传异质性
  • 批准号:
    BB/D524040/2
  • 财政年份:
    2008
  • 资助金额:
    $ 47.75万
  • 项目类别:
    Research Grant
The interplay between host and pathogen genetics in the increasing incidence of bovine tuberculosis
宿主和病原体遗传学之间的相互作用导致牛结核病发病率增加
  • 批准号:
    BB/E018335/2
  • 财政年份:
    2008
  • 资助金额:
    $ 47.75万
  • 项目类别:
    Research Grant
Faraday earmarked proposal: Toll-like receptors and dendritic cell genetic heterogeneity
法拉第专项提案:Toll 样受体和树突状细胞遗传异质性
  • 批准号:
    BB/D524040/1
  • 财政年份:
    2006
  • 资助金额:
    $ 47.75万
  • 项目类别:
    Research Grant

相似国自然基金

脊髓新鉴定SNAPR神经元相关环路介导SCS电刺激抑制恶性瘙痒
  • 批准号:
    82371478
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
面向人工智能生成内容的风险识别与治理策略研究
  • 批准号:
    72304290
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
白桦雄花早期发育转录组分析及重要基因功能鉴定
  • 批准号:
    31100449
  • 批准年份:
    2011
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
言语提取方案对人工耳蜗植入者声调与音乐识别的影响
  • 批准号:
    81070796
  • 批准年份:
    2010
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目
用基因确认标签技术(GIS)筛选东方蜜蜂的抗螨基因
  • 批准号:
    31072095
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目
链霉菌702所产抗真菌物质的化学结构的鉴定
  • 批准号:
    30960011
  • 批准年份:
    2009
  • 资助金额:
    23.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgaris
桥粒芯糖蛋白 3 嵌合自身抗体受体 T 细胞 (DSG3-CAART) 对粘膜寻常型天疱疮的免疫调节作用
  • 批准号:
    10679911
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
Influence of viral and immune interventions on early events following oral SIV infection
病毒和免疫干预对口腔 SIV 感染后早期事件的影响
  • 批准号:
    10628249
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
Single-molecule protein sequencing by detection and identification of N-terminal amino acids
通过检测和鉴定 N 端氨基酸进行单分子蛋白质测序
  • 批准号:
    10646060
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
MultiOMICS mechanistic identification of predictors of HIV DNA decay, restoration of immune homeostasis and HIV specific immunity in PWH with cancer receiving Immune check point therapy
接受免疫检查点治疗的癌症患者中 HIV DNA 衰变、免疫稳态恢复和 HIV 特异性免疫的预测因子的多组学机制鉴定
  • 批准号:
    10731665
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
Identification of serological markers of protection and risk for dengue vaccines and natural infection
鉴定登革热疫苗和自然感染的保护和风险的血清学标记
  • 批准号:
    10638037
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
Development of Immunological Reagents for the Identification of New World Monkey Biomarkers
开发用于鉴定新世界猴生物标志物的免疫试剂
  • 批准号:
    10807651
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
Screening strategies and social determinants of health among people with high risk of anal cancer
肛门癌高危人群的筛查策略和健康社会决定因素
  • 批准号:
    10762863
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
A Novel Immunological-Directed Synthetic Biology-Based Drug for the Treatment of Multiple Sclerosis
一种用于治疗多发性硬化症的新型免疫导向合成生物学药物
  • 批准号:
    10693465
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir
多组学鉴定和验证免疫干预触发的机制,旨在减少复制能力储库的大小
  • 批准号:
    10731661
  • 财政年份:
    2023
  • 资助金额:
    $ 47.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了